FDA Adverse Event Malfunction Summary report: N

ALINITY C PROCESSING MODULE

MDR report key: 22068513 · Received May 22, 2025

Report

Report Number
3016438761-2025-00303
Event Type
Malfunction
Date Received
May 22, 2025
Date of Event
May 8, 2025
Report Date
June 25, 2025
Manufacturer
ABBOTT LABORATORIES
Product Code
JJE
UDI-DI
00380740137380
PMA / PMN Number
K170316
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. SECTION A1 SID ADDED ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE.

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE.

Additional Manufacturer Narrative · 0

DURING THE SUBSEQUENT SITE VISIT BY THE FIELD SERVICE ENGINEER (FSE) THE ANALYZER WAS INSPECTED, AND VARIOUS DIAGNOSTIC CHECKS OF THE SYSTEM, AND REPLACING PARTS (WASH CUP, REAGENT PROBES AND A NOZZLE). A REVIEW OF THE ANALYZER SERVICE HISTORY AND LOGS IDENTIFIED NO CONTRIBUTING FACTORS TO THE CURRENT COMPLAINT. THERE HAVE BEEN NO FURTHER OCCURRENCES OF DISCREPANT RESULTS AFTER THE SITE VISIT BY THE FSE. THE ALINITY SYSTEMS OPERATIONS MANUAL ADDRESSES SAMPLE RESULTS OBSERVED PROBLEMS FOR ERRATIC RESULTS. MANUFACTURING DOCUMENTATION FOR THE LIKELY CAUSE DID NOT IDENTIFY ANY ISSUES ASSOCIATED WITH THE COMPLAINT ISSUE. A REVIEW OF THE CLINICAL CHEMISTRY PLATFORMS TRACKING AND TRENDING DATA REVEALED NO SYSTEMIC ISSUES OR TRENDS ASSOCIATED WITH THE DISCREPANT RESULT DESCRIBED IN THIS COMPLAINT. BASED ON THE INVESTIGATION NO SYSTEMIC ISSUE OR DEFICIENCIES WERE IDENTIFIED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSELY DECREASED SODIUM RESULT GENERATED ON THE ALINITY C PROCESSING MODULE ON A PATIENT. THE FOLLOWING RESULTS WERE PROVIDED: SID (B)(6) = 105 / 139 MMOL/L, (REFERENCE RANGE: 133-146 MMOL/L) NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSELY DECREASED SODIUM RESULT GENERATED ON THE ALINITY C PROCESSING MODULE ON A PATIENT. THE FOLLOWING RESULTS WERE PROVIDED: 105 / 139 MMOL/L, (REFERENCE RANGE: 133-146 MMOL/L). NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSELY DECREASED SODIUM RESULT GENERATED ON THE ALINITY C PROCESSING MODULE ON A PATIENT. THE FOLLOWING RESULTS WERE PROVIDED: SID (B)(6) = 105 / 139 MMOL/L, (REFERENCE RANGE: 133-146 MMOL/L) NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1220526 ALINITY C PROCESSING MODULE ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE JJE ABBOTT LABORATORIES 00380740137380

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ALNTY C ICT SAMPLE DILU, 07P53-20, 77016UN24| ALNTY C ICT SAMPLE DILU, 07P53-20, 77016UN24| ALNTY C ICT SAMPLE DILU, 07P53-20, 77016UN24